2020

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

HAI Releases Annual Report 2019

Why TRIPS flexibilities are a crucial mechanism for access to medicines

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

To tackle COVID-19 pandemic, transparency and collaboration are vital

Ensure transparency, affordability and availability of vaccines and treatments for COVID-19, say MEPs

HAI Follows Dutch Government Advice in Response to COVID-19

Europe’s Beating Cancer Plan

Niets magisch aan medicijnprijzen

Nothing magical about medicine prices

US puts pressure on the Netherlands over compulsory licenses

A busy week at the Court of Justice of the European Union

2019

How to measure change in EU Policy

Health Technology Assessments: will 2020 end the deadlock?

Is clinical trial transparency under threat?

REBRAND: Fact or Fiction publication

An insightful day at the EURIPID stakeholder meeting in Budapest

A Momentous Week for Access to Medicines

Dr Marg Ewen Receives the Helen Clark-JoPPP Award

No Universal Health Coverage without Universal Medicines Coverage

2018

A Year at the Heart of Regulatory Decision Making

Staff Spotlight: Jaume Vidal

Time for a Treaty? ReAct Reports on Second Consultation on Global Development & Stewardship Framework to Combat AMR

Medicijnen: de link met de maatschappij

What Role Can Civil Society Play in the European Regulatory Process?

Open Science for Health: Shaping the New Framework Programme